Medical Treatment of Cholesterol Gallstones by Bile Desaturating Agents
1984; Lippincott Williams & Wilkins; Volume: 4; Issue: Supplement 2 Linguagem: Inglês
10.1002/hep.1840040837
ISSN1527-3350
Autores Tópico(s)Gallbladder and Bile Duct Disorders
ResumoHepatologyVolume 4, Issue S2 p. 199S-208S ArticleFree Access Medical Treatment of Cholesterol Gallstones by Bile Desaturating Agents Alan F. Hofmann, Alan F. Hofmann Department of Medicine, University of California at San Diego, San Diego, California 92103Search for more papers by this author Alan F. Hofmann, Alan F. Hofmann Department of Medicine, University of California at San Diego, San Diego, California 92103Search for more papers by this author First published: September/October 1984 https://doi.org/10.1002/hep.1840040837Citations: 47AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat 1 Langenbuch C. Ein Fall von Exstirpation der Gallenblase wegen chronischer Cholelithiasis. Heilung. Berl Klin Wochenschr 1882; 19: 725–727. (For translation see Amnion HV, Hofmann AF. The Langenbuch paper. I. An historical perspective and comments of the translators. II. A translation. Gastroenterology 1983; 85: 1426–1433. ) 2 Berk RN. Gallstones: diagnostic imaging in historical perspective. The Pharos of Alpha Omega Alpha 1983; 45: 30–34. 3 Ingelfinger FJ. Digestive disease as a national problem. V. Gallstones. Gastroenterology 1968; 55: 102–104. 4 Schiff M. II coleinato di soda nella cura dei calcoli biliari. L'lmpar-ziale 1873; 13: 97–99. 5 Vlahcevic ZR, Bell CC Jr, Buhac I, et al. Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970; 59: 165–173. 6 Thistle JL, Schoenfield LJ. Induced alterations of bile composition in persons having cholelithiasis. Gastroenterology 1971; 61: 488–496. 7 Danzinger RG, Hofmann AF, Schoenfield LJ, et al. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972; 286: 1–8. 8 Bell GD, Whitney B, Dowling RH. Gallstone dissolution in man using chenodeoxycholic acid. The Lancet 1972; 2: 1213–1216. 9 Iser JH, Sali A. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. Drugs 1981; 21: 90–119. 10 Dowling RH. Chenodeoxycholic acid therapy of gallstones. Clin Gastroenterol 1977; 6: 141–163. 11 Schoenfield LJ, Lachin JM, the NCGS Steering Committee, et al. National Cooperative Gallstone Study: a controlled trial of the efficacy and safety of chenodeoxycholic acid for dissolution of gallstones. Ann Intern Med 1981; 94: 257–282. 12 Lachin JM, Schoenfield LJ for the National Cooperative Gallstone Study Group. Effects of dose relative to body weight in the National Cooperative Gallstone Study, a fixed-dose trial. Controlled Clin Trials 1983; 4: 125–131. 13 Schoenfield LJ, Grundy SM, Hofmann AF, et al. The National Cooperative Gallstone Study viewed by its investigators. Gastroenterology 1983; 84: 644–648. 14 Hammarsten O. Untersuchungen ueber die Gallen einiger Polar-thiere. I. Ueber die Galle des Eisbaeren. I. Abschnitt. Hoppe-Seyler's Z Physiol Chem 1901; 32: 435–466 and II. Abschnitt. 1902; 36: 525–555. 15 Iwasaki T. Ueber die Konstitution der Urso-desoxycholsaeure. Z Physiol Chem 1936; 244: 181–193. 16 Sugata F, Shimizu M. Retrospective studies on gallstone disappearance. Jpn J Gastroenterol 1974; 71: 75–80. 17 Nakagawa S, Makino I, Ishizaki T, et al. Dissolution of cholesterol gallstones by ursodeoxycholic acid. The Lancet 1977; 2: 367–369. 18 RH Dowling, AF Hofmann, L Barbara (Editors). Workshop on Ursodeoxycholic Acid. Baltimore: University Park Press, 1979. 19 Weis HJ, Holtermueller KH, Stiehl A, et al. Clinical experience in bile composition in patients taking ursodeoxycholic acid for gallstone dissolution. In: G Paumgartner, A Stiehl, W Gerok, eds. Biological effects of bile acids. Lancaster, England: MTP Press, 1979: 90–102. 20 Northfield TC, LaRusso NF, Hofmann AF, et al. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut 1975; 16: 12–17. 21 Einarsson K, Grundy S. Effects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of biliary lipids in man. J Lipid Res 1980; 21: 23–34. 22 Higuchi WI, Su CC, Park JY, et al. Mechanism of cholesterol gallstone dissolution Analysis of the kinetics of cholesterol monohydrate dissolution and taurocholate/lecithin solutions by the Mazer, Benedek, and Carey model. J Phys Chem 1981; 85: 127–129. 23 Corrigan OI, Su CC, Higuchi WI, et al. Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions. New mechanism for gallstone dissolution in humans. J Pharm Sci 1980; 69: 869–970. 24 Su CC, Park JY, Higuchi WI, et al. Mesophase formation during in vitro cholesterol gallstone dissolution: a specific effect of ursodeoxycholic acid. J Pharm Sci 1981; 70: 713–715. 25 Igimi H, Carey MC. Cholesterol gallstone dissolution in bile: Dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates. J Lipid Res 1981; 22: 254–270. 26 Gilmore IT, Barnhart JL, Hofmann AF, et al. Effects of individual taurine-conjugated bile acids on biliary secretion and sucrose clearance in the unanesthetized dog. Am J Physiol 1982; 5: G40–G46. 27 Angelin B, Ewerth S, Einarsson K. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels. J Lipid Res 1983; 24: 461–468. 28 LaRusso NF. The role of bile acids in intestinal absorption of cholesterol. In: L Barbara, RH Dowling, AF Hofmann, et al., eds. Bile acids in gastroenterology. Lancaster, England: MTP Press, 1983. 29 Tangedahl TN, Thistle JL, Hofmann AF, et al. Effect of β-sitos-terol alone or in combination with chenic acid on cholesterol saturation of bile and cholesterol absorption in gallstone patients. Gastroenterology 1979; 76: 1341–1346. 30 Fitzpatrick G, Neutra R, Gilbert JP. Cost-effectiveness of cholecystectomy for silent gallstones. In: JP Bunker, BA Barnes, F Mos-teller, eds. Costs, risks, and benefits of surgery. New York: Oxford University Press, 1977: 246–261. 31 Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis: a review. Dig Dis Sci 1982; 27: 737–761 and 833–856. 32 Podda M, Zuin M, Dioguardi ML, et al. A combination of cheno-deoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation. Hepatology 1982; 2: 334–339. 33 Igimi H, Carey MC. pH-solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena. J Lipid Res 1980; 21: 72–90. 34 Hofmann AF. Pharmacology of chenodeoxycholic and ursodeoxycholic acid in man. In: G Paumgartner, A Stiehl, W Gerok, eds. Bile acids and cholesterol in health and disease. Boston: MTP Press Limited, 1983: 301–336. 35 Roda E, Mazzella G, Grigolo B, et al. Effect of tauroursodeoxycholic acid administration on bile lipid secretion in man. In: G Paumgartner, A Stiehl, W Gerok, eds. Bile acids and cholesterol in health and disease. Boston: MTP Press Limited, 1983: 269–273. 36 Batta AK, Salen G, Shefer S, et al. The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition. Hepatology 1982; 2: 811–816. 37 Maton P, Murphy G, Dowling R. Lack of response to chenodeoxycholic acid in obese and non-obese subjects. Gut 1980; 21: 1082–1086. 38 Bateson MC, Bouchier IAD, Trash DB, et al. Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid. Br Med J 1981; 283: 645–646. 39 Dumont M, Erlinger S, Uchman S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology 1980; 79: 82–89. 40 Cumming SSA, Hofmann AF. Physiological determinants of biliary calcium secretion in the dog. Gastroenterology 1984 (in press). 41 Palmer RH. Bile acids, liver injury, and liver disease. Arch Intern Med 1972; 130: 606–617. 42 Hardison WGM, Hatoff DE, Miyai K, et al. Nature of bile acid maximum secretory rate in the rat. Am J Physiol 1981; 241 (GI and Liver 4): G337–G344. 43 LaRusso NF, Szczepanik PA, Hofmann AF, et al. The effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects. Gastroenterology 1977; 72: 132–140. 44 Gadacz TR, Allan RN, Mack E, et al. Impaired lithocholate sulfation in the rhesus monkey: a possible mechanism for chenodeoxy-cholate toxicity. Gastroenterology 1976; 70: 1125–1129. 45 Palmer RH, McSherry CK. Lithocholate metabolism in baboons fed chenodeoxycholate. J Lab Clin Med 1982; 99: 533–538. 46 Allan RN, Thistle JL, Hofmann AF, et al. Lithocholate metabolism during chenotherapy for gallstone dissolution. I. Serum levels of sulfated and unsulfated lithocholates. Gut 1976; 17: 405–412. 47 Marks JW, Sue SO, Pearlman BJ, et al. Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones. J Clin Invest 1981; 68: 1190–1196. 48 Stiehl A, Ast E, Czygan P, et al. Elevated transaminases following treatment of patients with cholesterol gallstones with chenodeoxycholic acid. Inn Med 1976; 3: 75–80. 49 Phillips MJ, Fisher RL, Anderson DW, et al. Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid (CDCA) therapy in patients with cholelithiasis: The National Cooperative Gallstone Study (NCGS). Hepatology 1983; 3: 209–220. 50 Fisher RL, Anderson DW, Boyer JL, et al. A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis: The National Cooperative Gallstone Study (NCGS). I. Light microscopy. Hepatology 1982; 2: 187–201. 51 Mekhjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest 1971; 50: 1569–1577. 52 Chadwick VS, Gaginella TS, Carlson GL, et al. Effect of molecular structure on bile acid induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med 1979; 94: 661–674. 53 Shapero TF, Rosen IE, Wilson SR, et al. Discrepancy between ultrasound and oral cholecystography in the assessment of gallstone dissolution. Hepatology 1982; 2: 587–590. 54 Marks JW, Lan S-P, the Steering Committee, et al. Low dose chenodiol to prevent gallstone recurrence after dissolution therapy. Ann Intern Med 1984; 100: 376–381. References 1 Sama C, LaRusso NF, Lopez del Pino V, et al. Effects of acute bile acid administration on biliary lipid secretion in healthy volunteers. Gastroenterology 1982; 82: 515–525. 2 van Berge Henegouwen GP, Hofmann AF. Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. Gastroenterology 1978; 75: 879–885. 3 Bateson MC, Bouchier IAD, Trash DB, et al. Calcification of radiolucent gall stones during treatment with ursodeoxycholic acid. Br Med J 1981; 283: 645–646. 4 Cummings SA, Hofmann AF. Physiological determinants of biliary calcium secretion in the dog. Gastroenterology 1984 (in press). 5 Hutton SW, Sievert CE Jr, Vennes JA, et al. The effect of sphincterotomy on gallstone formation in the prairie dog. Gastroenterology 1981; 81: 663–667. 6 Kwan KH, Higuchi WI, Molokhia AM, et al. Cholesterol gallstone dissolution rate accelerators. I. Exploratory investigations. J Pharm Sci 1977; 66: 1105–1108. 7 Danzinger RG, Hofmann AF, Schoenfield LJ, et al. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis. J Clin Invest 1973; 52: 2809–2821. 8 Thistle JL, LaRusso NF, Hofmann AF, et al. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man: a dose response study. Dig Dis Sci 1982; 12: 161–168. 9 Einarsson K, Nilsell K, Angelin B, et al. Effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and secretion rates of biliary lipids in man. In: G Paumgartner, A Stiehl, W Gerok. Bile acids and cholesterol in health and disease. Boston: MTP Press Limited, 1983: 267–268. Citing Literature Volume4, IssueS2September/October 1984Pages 199S-208S ReferencesRelatedInformation
Referência(s)